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{ Interaction between cell and extracellular matrix plays a crucial role in tumour invasion and metastasis. Using an immortalised
human bronchial epithelial (BEP2D) cell model, the study here shows that expression of Betaig-h3 gene, which encodes a
secreted adhesion molecule induced by transforming growth factor-b, is markedly decreased in several independently
generated, radiation-induced tumour cell lines (TL1–TL5) relative to parental BEP2D cells. Transfection of Betaig-h3 gene into
tumour cells resulted in a signiﬁcant reduction in tumour growth. While integrin receptor a5b1 was overexpressed in tumour
cells, its expression was corrected to the level found in control BEP2D cells after Betaig-h3 transfection. These data suggest
that Betaig-h3 gene is involved in tumour progression by regulating integrin receptor a5b1. The ﬁndings provide strong
evidence that the Betaig-h3 gene has tumour suppressor function in human BEP2D cell model and suggest a potential target
for interventional therapy.
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Tumour growth and metastasis is a multistep process involving cell
adhesion, extracellular matrix (ECM) degradation and cell migration
(Tlsty, 1998). The integrin superfamily consists of a major class of
transmembrane glycoproteins that mediate cell–ECM and cell–cell
adhesion (Giancotti and Ruoslahti, 1999). Loss or gain of expression
of speciﬁc integrin has been implicated in malignant transformation,
tumour progression and metastasis (Mizejewski, 1999). There is
evidence that osteosarcoma cells that overexpress integrin a5b1
show reduced invasive potential (Giancotti and Ruoslahti, 1990).
In contrast, upregulation of a5b1 has been shown to correlate with
invasive phenotype in colon cancer and transitional cell carcinoma
(Saito et al, 1996; Gong et al, 1997). Similarly, recent data show that
high levels of integrin a6 in breast cancer and avb3 in melanoma
correlate with tumour progression (Mukhopadhyay et al, 1999;
Hofmann et al, 2000). Therefore, depending on the cell type and
tumour model, expression of various integrin subunits may contri-
bute either positively or negatively to the transformed phenotype.
Betaig-h3 is a secreted protein induced by transforming growth
factor-b (TGF-b) in human adenocarcinoma cells as well as other
human cell types (Skonier et al, 1992). Although transfection of
Betaig-h3 gene into CHO (Chinese Hamster Ovary) ﬁbroblasts
markedly reduces their ability to form tumours in nude mice
(Skonier et al, 1994), its expression as well as regulation in human
tumour has not been examined until now. There is evidence that
mutations or altered expression of this gene are involved in corneal
dystrophy and osteogenesis in human (Bron, 2000; Kim et al,
2000a). In addition, Betaig-h3 protein is a component of ECM
in lung, bladder and skin (LeBaron et al, 1995; Billings et al,
2000a,b), which promotes adhesion and the spreading of dermal
ﬁbroblasts in vitro and mediates cell adhesion by interacting with
a3b1 integrin in human corneal epithelial cells (Billings et al,
2000b; Kim et al, 2000b). These data suggest that Betaig-h3 protein
is involved in cellular adhesion and imply an important role of this
gene in the process of human tumour progression.
Although in vitro transformation studies with human cells are
highly desirable in studying the molecular events associated with
malignant conversion, such studies, thus far, have not been success-
ful with primary human epithelial cells (Hei et al, 1994). Using
papillomavirus-immortalised human bronchial epithelial (BEP2D)
cells, we have previously shown that a-particles can malignantly
transform these cells in a stepwise fashion before they become
tumorigenic and metastatic in nude mice. It should be stated that
although these cells are immortalised, they do not possess any other
transformed phenotypes and only after carcinogen treatment, and
extended subculturing, do transformed/tumorigenic phenotypes
emerge in a sequential fashion (Hei et al, 1994, 1996). The BEP2D
cell model is, therefore, useful in studying the genetic events
involved in tumour progression. In the present study, we show that
ectopic expression of Betaig-h3 gene in radiation-induced tumour
cells signiﬁcantly suppresses their in vivo tumorigenicity. This ﬁnd-
ing provides strong evidence that Betaig-h3 has tumour suppressor
function in human BEP2D cells.
MATERIALS AND METHODS
Cell culture
Tumorigenic BEP2D cells were derived previously from treat-
ment of exponentially growing BEP2D cells with a single
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www.bjcancer.com60 cGy dose of alpha-particles (Hei et al, 1996). Tumours larger
than 1 cm in diameter were resected from nude mice and used
to establish independently-generated cell lines (TL1–TL5). The
BEP2D cells and tumour cell lines were maintained in serum-
free LHC-8 medium supplemented with growth factors as
described previously (Hei et al, 1994). Primary human bronchial
epithelial (NHBE) cells were purchased from Clonetics (catalo-
gue no: CC-2541) and grown in BEGM medium (Clonetics).
cDNA array and Northern blotting
cDNA array (Clontech) was hybridised with
32P-labelled cDNA
probes prepared by reverse transcription using 1 mg mRNA from
control BEP2D and TL1 tumour cells as described previously
(Zhao et al, 2001). The hybridisation signals were analysed by auto-
radiography and further quantiﬁed by phosphorimaging
(ImageQuant software). The expression levels of b-actin and
G3PDH housekeeping genes were used as standards for normalis-
ing the expression levels of other genes.
For Northern blot, 2.5 mg of mRNA was denatured and sepa-
rated on a 1% denaturing agarose formaldehyde gel. The
mRNAs were then transferred on nylon membrane (Millipore
Corp., Bedford) by downward capillary blotting in 206SSC
(3 M NaCl, 0.3 M Na3Citrate×2H2O, pH 7.0) followed by UV
cross-linking. Speciﬁc probe was generated by labelling of PCR-
ampliﬁed cDNA fragments with [a-
32P]dCTP using random
primed DNA labelling kit (Boehringer, Mannheim). The
membranes were pre-hybridised for 30 min and then hybridised
with cDNA probe in ExpressHyb TM hybridisation solution
(Clontech) for 8–12 h at 688C. The blots were washed twice in
26SSC, 0.1% SDS at room temperature for 15 min followed by
washing twice in 0.26SSC, 0.1% SDS at 558C for 15 min. The
membranes were exposed to Kodak BioMax ﬁlm at –708C for
12–72 h. The band intensities were evaluated by phosphorima-
ging and normalised to b-actin expression level.
All probes for Northern blot were acquired by PCR ampliﬁed
gene fragments using the following primer sets: a5: 5'-AGAGC-
CAAAGTCTGCAGTTG-3',5 '-CTGGAGGCTTGAGCTGAGCT-3';
b1: 5'-GTGTTCAGTGCAGAGCCTTCA-3',5 '-CTTCGGATTGA
CCACAGTTG-3'; b-actin: 5'-GTTGCTATCCAGGCTGTGC-3',5 '-
GCATCCTGTCGGCAATGC-3'.
Cloning and sequencing of Betaig-h3 cDNA
The ﬁrst strand cDNA was synthesised from 0.2 mg poly(A)
+ RNA
isolated from NHBE cells using Superscript II reverse transcriptase
and oligo(dT) primer (Gibco). Human Betaig-h3 cDNA was then
PCR-ampliﬁed using high-ﬁdelity MasterAmp
TM DNA polymerase
(Epicenter, Madson, WI, USA) and synthetic primers (5'-
GTTAAGCTTGCTTGCCCGTCGGTCGCTAGCT-3',5 '-GCTCTA-
GAGCCTCCAAGCCACGTGTAGATGT-3') that included HindIII
and XbaI restriction enzyme recognition sites. The ampliﬁed whole
length cDNA was subcloned into the HindIII and XbaI-digested
pRc/CMV2 expression vector (Invitrogen). The sequence analysis
showed that the protein sequence is 100% identical with that
report in GeneBank (accession no: M77349) with the exception
of several modiﬁed nucleotide sites such as 698 (C?G), 1667
(T?C) and 1118 (C?T).
Transfection of TL1 tumour cells with Betaig-h3 cDNA
TL1 tumour cells were plated at 1.5610
6 per 60 mm dish in
serum-free LHC-8 medium. When 70–80% conﬂuent, they
were transfected with either pRc/CMV2-Betaig-h3 or pRc/
CMV2 (2 mg/dish) for 24 h using lipofectamin (Gibco) accord-
ing to the manufacturer’s instruction. The cells were split at
1:10 and cultured in the medium containing 500 mgm l
71
of the G418 (Gibco) for 21 days. Colonies were isolated
using cloning ring and maintained in the presence of
300 mgm l
71 of G418.
Immunoprecipitation and Western blotting
For screening the a5 and b1 integrin subunit expression, immuno-
precipitations were carried out on surface-biotinylated cells as
previously described (Trusolino et al, 1998). For analysis of
Betaig-h3 protein expression, conditioned medium was collected
from conﬂuent culture and the protein was then concentrated
using SP sepharose (Amersham) and eluted using SDS sample
buffer by boiling 5 min (Billings et al, 2000b). Protein concentra-
tions were measured by Bio-Rad DC protein assay kit. Samples
containing equal amounts of proteins were then fractionated by
SDS–PAGE gel, transferred onto Hybond membrane, and immu-
noblotted with 1:1000 dilution of anti-Betaig-h3 human
polyclonal antibody (kindly provided by Dr Paul C Billings).
Peroxidase-conjugated anti-rabbit IgG was used to detect Betaig-
h3 level by ECL procedures.
In vitro growth rate
Growth curves of TL1 and Betaig-h3-transfected tumour cells were
performed by plating 5610
4 cells into 25 cm
2 ﬂask. Cell numbers
were determined using Coulter Counter. The results at each time
point were the mean value of eight cultures from two independent
experiments.
Anchorage-independence growth and tumorigenicity in
nude mice
Anchorage-independence assays were performed by plating the
Betaig-h3-transfected and control BEP2D cells in 0.35% agar on
the layer of 0.7% agar. Colonies 510 cells in number were counted
after 4 weeks. Tumorigenicity assay was performed as described
previously (Hei et al, 1994). Brieﬂy, Betaig-h3- or empty vector-
transfected tumour cells were injected subcutaneously into nude
mice at the left ﬂanks. Tumours were palpated and measured with
calipers and tumour volume calculated as (longest diameter6
(shortest diameter)
2)60.5. Control animals were inoculated with
either control BEP2D cells or with radiation-induced TL1 tumour
cells. For each cell line, two independent experiments were
performed.
RESULTS
Betaig-h3 is downregulated in radiation-induced tumour
cell lines
Tumorigenic BEP2D cells were established by exposing the non-
tumorigenic, immortalised parental cells to a single 60 cGy dose
of a-particles as described (Hei et al, 1996). A series of primary
and secondary tumour cell lines (TL1–TL5) were established from
tumour nodules developed in nude mice. By using cDNA array
techniques, a series of genes were identiﬁed that were differentially
expressed in radiation-induced tumour cells relative to parental
BEP2D cells (Zhao et al, 2001). Among these genes, Betaig-h3
expression was markedly decreased in tumour cells (Figure 1A).
The result was further conﬁrmed by Northern blot using mRNAs
obtained from different passages of transformed cells and ﬁve
tumour cell lines (Figure 1B). In early-passaged cells (1 week after
radiation), no change in Betaig-h3 expression was found when
compared with control BEP2D cells. However, the expression of
Betaig-h3 was downregulated by 2.4-fold in late-passaged cells (just
before inoculating into nude mice) and between 7.5–9-fold in all
ﬁve tumour cell lines examined. These results indicate that
decreased expression of Betaig-h3 gene might be related to the
acquisition of malignant phenotype in BEP2D cells.
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suppresses their colony-forming efﬁciency in soft agar and
tumorigenicity in nude mice
To examine the signiﬁcance of Betaig-h3 downregulation in malig-
nant conversion, we recovered the expression of Betaig-h3 gene in a
representative tumour cell line (TL1) with pRc/CMV2-Betaigh3
vector. Two G418-resistant colonies (TL1-clones 18 and TL1-clone
28) that expressed different levels of Betaig-h3 were chosen for
further studies. From the Northern and Western blot results
(Figure 2A), the parental TL1 and TL1-pRc/CMV2 cells (vector
control) expressed similar levels of Betaig-h3, which were lower
than control BEP2D cells. After Betaig-h3 transfection, the expres-
sion of this gene in TL1-clone 18 was recovered to a level similar to
that of control BEP2D cells, whereas TL1-clone 28 had a four-fold
higher expression level. Expression of the Betaig-h3 gene in primary
human bronchial epithelial (NHBE) cells and control BEP2D cells,
on the other hand, was similar both at the mRNA and protein
levels (Figure 2A).
TL1-clone 18 and TL1-clone 28 cells grew much slower and
showed lower saturation density than parental TL1 tumour cells
(Figure 2B). The doubling time of cells transfected with the
empty vector was 32 h, which was similar to that of TL1 tumour
cells. In contrast, clone 18 and 28 cell lines grew slower than
TL1, with doubling times of about 55 h. We also checked their
colony-forming efﬁciency in soft agar (Table 1). The result
showed that there was no signiﬁcant difference between parental
TL1 and TL1-pRc/CMV2 cells (2.39 and 2.28%, respectively with
P40.05). However, TL1-clone 18 and TL1-clone 28 cells resulted
in a signiﬁcantly lower ability of anchorage independent growth
with colony-forming efﬁciency in agar of 0.29 and 0.34%, respec-
tively (P50.01).
To determine whether ectopic expression of the Betaig-h3 gene
suppresses tumour formation in vivo,5 610
6 of each of the
following cell types were subcutaneously injected into nude mice:
control BEP2D cells, TL1 tumour cells, TL1-pRc/CMV2 and
Betaig-h3-transfected cells (clone 18 and 28). The tumour volumes
were measured weekly during the experiments. As shown in Table
1, no tumours (zero out of eight mice) were found in parental
BEP2D cells after monitoring for more than 20 weeks. However,
eight out of eight mice that were injected with either TL1 or
TL1-pRc/CMV2 tumour cells developed progressively growing
tumours with average volumes of 1021.8+330.7 mm
3 and
970.6+295.6 mm
3, respectively. In contrast, four out of eight
mice with TL1-clone 18 and ﬁve out of eight mice with TL1-clone
28 cells formed only small nodules. The volume, which averaged
86.7+32.3 mm
3, was signiﬁcantly smaller than that of parental
TL1 tumour cells (P50.01). Meanwhile, tumour growth was
signiﬁcantly suppressed in tumour cells after Betaig-h3 transfection
(Figure 2C).
Betaig-h3 gene is related to the expression level of integrin
receptor a5b1
Previous studies have suggested that Betaig-h3 protein affect cell–
ECM interaction through regulation of integrin receptor (LeBaron
et al, 1995; Billings et al, 2000a,b). Using cDNA array, it was found
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Figure 1 Differential expression of Betaig-h3 gene in control BEP2D and radiation-induced tumour cells. (A) Human cytokine/receptor array results
(Clontech Catalogue no: 7744–1). Arrows indicate the cDNA spots of Betaig-h3 on the membrane. (B) Northern blot analysis of Betaig-h3 gene in control
BEP2D cells, early passage cells (1 week post radiation), late passage cells (just before inoculation into nude mice) and ﬁve tumour cell lines (TL1–TL5). The
blots were hybridised to
32P-labelled Betaig-h3 cDNA probes. After stripping, the membranes were rehybridised to human b-actin probe.
Table 1 Suppression of anchorage-independent growth and tumorigeni-
city by Betaig-h3 gene
Cell type
CFE in soft
agar (%)
b
Tumours/
total mice
Tumour volume at
4 weeks (mm
3)
BEP2D cells 0.02 0/8 –
TL1 tumour cells 2.39+0.29 8/8 1021.8+330.7
TL1-pRc/CMV2 2.28+0.37 8/8 970.6+295.6
TL1-Betaig-h3 clone 18 0.29+0.05
a 4/8 9/16 86.7+32.3
a
TL1-Betaig-h3 clone 28 0.34+0.07
a 5/8
The colonies in soft agar were counted and tumour volumes were measured as
described in Materials and Methods.
aP50.01, compared with parental tumour
cells.
bCFE, Colony Forming Efﬁciency.
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tumour cells (data not shown). To determine whether the expres-
sion of integrin receptor a5b1 correlated with Betaig-h3 gene
expression, we checked its mRNA and protein levels in Betaig-h3
transfected tumour cells. As shown in Figure 3, expression of a5
and b1 subunits was ﬁve- and three-fold higher, respectively, in
parental TL1 and TL1-pRc/CMV2 cells than in control BEP2D
cells. However, after transfecting Betaig-h3 gene into TL1 tumour
cells, expression of a5b1 integrin (clone 18 and 28 cells) decreased
to level of control BEP2D cells. This data were further conﬁrmed
by immunoprecipitation using monoclonal antibody for a5 and
b1. We further checked the mRNA expression of integrin subunits
a1-a4, a6, av and b2-b3. No signiﬁcant changes in their expression
were found among control BEP2D, TL1 tumour cells and Betaig-
h3-transfected TL1 tumour cells (data not shown).
DISCUSSION
In an attempt to identify genes involved in the progression of lung
carcinoma, cDNA arrays were used to screen differentially
expressed genes between control BEP2D and radiation-induced
tumour cells. Altered expression of a series of genes that controlled
cellular growth and differentiation between these two cell models
was found (Zhao et al, 2001), with Betaig-h3 gene notably down-
regulated in tumour cells, a ﬁnding that was further conﬁrmed
in ﬁve tumour cell lines by Northern blot. Previous studies have
shown that Betaig-h3 gene is signiﬁcantly reduced in embryonal
rhabdomyosarcoma cell lines and mesenchymal tumours (Genini
et al, 1996; Schenker and Trueb, 1998), suggesting that Betaig-h3
may have an important role in human cancer. Although overex-
pression of this gene in CHO ﬁbroblast cells leads to a marked
decrease in their ability to form tumour in nude mice (Skonier
et al, 1994), little is known about its regulation in tumour progres-
sion of human tissues. In this study, we provide evidence that
ectopic expression of Betaig-h3 in TL1 tumour cells signiﬁcantly
inhibits colony-forming efﬁciency in soft agar, and tumour growth
in nude mice relative to parental tumour cells. This is the ﬁrst
evidence that Betaig-h3 gene has tumour suppressor function in
a human epithelium-derived tumour model.
Betaig-h3 is a secreted protein that promotes the adhesion of
dermal ﬁbroblasts and corneal epithelial cells (LeBaron et al,
1995; Billings et al, 2000a,b;). These ﬁndings imply that Betaig-
h3 gene affects cell–ECM interaction by regulating integrin recep-
tors. This study conﬁrms that acquisition of tumorigenic
phenotype of BEP2D cells is accompanied by an increased expres-
sion of a5b1 integrin receptor at both the mRNA and protein
levels. Ectopic expression of Betaig-h3 gene in tumorigenic cells
(TL1) led to downregulation of integrin and suppression of
tumorigenicity. The data suggest that Betaig-h3 gene is involved
in the tumorigenic process by regulating a5b1 expression. The
observation is consistent with other reports that a5b1, while
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Figure 2 (A) mRNA and protein levels of Betaig-h3 gene determined by
Northern blot and immunoblotting (IB) in normal NHBE, control BEP2D,
TL1 and Betaig-h3-transfected tumour cells. (B) In vitro growth rate of par-
ental TL1 and Betaig-h3-transfected tumour cells. Data represent
mean+s.d. of eight culture ﬂasks from two independent experiments.
(C) Inhibition of tumour growth by Betaig-h3 transfection relative to vector
alone and parental TL1 tumour cells. Results are expressed as the
mean+s.d. of 8–9 independent tumours.
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Figure 3 mRNA and protein levels of a5b1 determined by Northern
blot and immunoprecipitation (IP) in TL1 and Betaig-h3-transfected tumour
cells.
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SV40 large T-transformed human bronchial epithelial cells (Albel-
da and Buck, 1990; Schiller and Bittner, 1995). In non-small lung
carcinoma cells, higher levels of a5b1 expression represents a
negative prognostic factor (Adachi et al, 2000). Similar results
have also been shown with other human tissues that high levels
of a5b1 integrin is associated with more malignant phenotype
in melanoma, transitional and colon cell carcinomas (Saito et
al, 1996; Gong et al, 1997; Beliveau et al, 2000). The a5b1 integrin
favours cell survival and protects cells from apoptosis in vitro via
upregulation of anti-apoptotic Bcl-2, whereas resistance to apop-
tosis is a feature of many malignant cells (Zhang et al, 1995).
These data, together with our results, suggest a key role for
a5b1 overexpression in tumorigenicity of human bronchial epithe-
lial cells. Although there is evidence that the Betaig-h3 protein
mediates cell adhesion by interacting with a3b1 (Kim et al,
2000b), integrins are expressed in a cell-type- and stage-speciﬁc
manner (Ruoslahti, 1999). Examples of cell-type-speciﬁc integrins
include aIIb3 in platelets and a6b4 in epithelial cells. One group
of integrins is associated with migration and proliferation in
various types of cells. These ‘emergency integrins’ which include
a5b1, avb3, and avb6 (Sheppard, 1996) are particularly important
in cancer. However, no differential expression of a1-a4, a6, av
and b2-b3 integrin subunits was found between Betaig-h3 trans-
fected and parental TL1 tumour cells. The data suggest that
Betaig-h3 gene is involved in tumour progression of human bron-
chial epithelial cell model by regulating integrin receptor a5b1.
Altered cell–matrix interaction is an essential prerequisite step
in the invasive and metastatic cascade (Hart and Saini, 1992).
Our ﬁnding that normal NHBE and immortalised BEP2D cells
exhibit similar levels of Betaig-h3 expression suggests that loss of
its expression occur during late stage of tumour progression.
Previous data show that chromosome 5q31, where Betaig-h3 gene
has been regionally mapped to, is often deleted in leukaemias,
myelodysplastic syndromes and many human cancer such as renal
cell, oesophageal and lung carcinomas (Peralta et al, 1998; Wu et
al, 1998; Brezinova et al, 2000). These ﬁndings suggest that deletion
of Betaig-h3 gene is a frequent event in human cancer. The ques-
tion of whether reexpression of Betaig-h3 gene in human tumour
cell lines may result in suppression of tumorigenicity is currently
under investigation. Our present ﬁnding suggest that Betaig-h3
gene could be a novel diagnostic marker of tumour metastasis
and a potential target for cancer therapy.
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